Business

Dance Biopharm has announced a name change, saying that the company will now be known as Aerami Therapeutics. The company, which is developing the Dance 501 insulin SMI, said that it is also moving its headquarters from San Francisco, CA to Durham, NC, USA and is expanding its pipeline. The company recently presented results from the Phase 2 SAMBA 04 study of … [Read more...] about Dance Biopharm changes its name to Aerami Therapeutics, moves headquarters, adds to pipeline

The Australian government has awarded Victoria-based Lachesis Biosciences AUS$438,000 for commercialization of the company's rivastigmine nasal spray for the treatment of dementia in patients with Alzheimer's Disease. The Accelerating Commercialisation grant is designed to"help businesses turn good ideas into marketable products through activities such as trials, … [Read more...] about Lachesis Biosciences gets grant for commercialization of nasal spray for dementia

Canadian-based cannabis company TerrAscend has acquired exclusive distribution rights to Syqe Medical's Syqe medical cannabis inhaler in Canada, the companies announced. The Syqe inhaler, which uses cartridges loaded with medical cannabis plant material, has been available to patients for the treatment of pain in Israel since June 2019; previously, the inhaler was … [Read more...] about TerrAscend to distribute Syqe inhaler in Canada

Ruling on post-trial motions in a case in which a jury found in May 2019 that GSK had willfully infringed on a Vectura patent covering Ellipta, the presiding judge has upheld the jury's award of $89.7 million in damages to Vectura and has added an additional $10.5 million in damages based on GSK's continued infringement. The original award was based on 3% … [Read more...] about Judge increases award to Vectura in Ellipta case

Intranasal drug developer Optinose announced that it has issued $80 million in senior secured notes as part of a $150 million debt financing agreement with Pharmakon Advisors. The company plans to issue another $30 million in notes by mid-February 2020, "subject to the achievement of minimum Xhance revenues and certain other conditions." Optinose's Xhance fluticasone … [Read more...] about Optinose announces $150 million debt financing from Pharmakon Advisors

Satsuma Pharmaceuticals has announced an underwritten initial public offering of 5,500,000 shares of its common stock at $15.00 per share, with expected gross proceeds of $82.5 million. The underwriters of the offering also get a 30-day option to purchase additional shares of common stock (up to a total of 825,000 shares) at the same price. The company's common stock … [Read more...] about Satsuma looks to raise $82.5 million in IPO for continued development of intranasal DHE

Inhaled insulin developer Dance Biopharm announced that it has signed an agreement with DarioHealth to integrate its smart soft mist inhaler into DarioHealth's digital platform. The integration, which will allow patients using the SMI to get usage data in real time through a mobile app, is expected to be completed in time for upcoming clinical trials and would be … [Read more...] about Dance Biopharm announces deal with DarioHealth

Hikma Pharmaceuticals has agreed to acquire two nasal sprays as well as unit-dose nasal spray manufacturing assets from Insys Therapeutics, the company said. In June 2019, Insys declared bankruptcy and said that it would sell all of its assets. Hikma did not say how much it paid for the naloxone and epinephrine nasal sprays. Insys announced results from a dose … [Read more...] about Hikma acquires naloxone and epinephrine nasal sprays from Insys

Perrigo announced that it has settled a lawsuit filed by Endo Pharmaceuticals in May 2019 that alleged infringement of patents related to Nascobal cyanocobalamin nasal spray which expire in 2024. The terms of the settlement were not disclosed. Perrigo Executive VP and President, Rx Pharmaceuticals Sharon Kochan said, "This settlement is another example of our … [Read more...] about Perrigo and Endo settle suit over Nascobal nasal spray